VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 404 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2016. The put-call ratio across all filers is 0.94 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $317,000 | -60.3% | 3,125 | -30.2% | 0.02% | -61.9% |
| Q3 2015 | $799,000 | -27.9% | 4,480 | -10.2% | 0.06% | +1.6% |
| Q2 2015 | $1,108,000 | -10.6% | 4,989 | -20.0% | 0.06% | +12.7% |
| Q1 2015 | $1,239,000 | -5.0% | 6,236 | -31.5% | 0.06% | -6.8% |
| Q4 2014 | $1,304,000 | -13.6% | 9,107 | -20.8% | 0.06% | -11.9% |
| Q3 2014 | $1,509,000 | -41.8% | 11,504 | -44.1% | 0.07% | -40.7% |
| Q2 2014 | $2,594,000 | -2.3% | 20,570 | +2.1% | 0.11% | -6.6% |
| Q1 2014 | $2,656,000 | +11.2% | 20,148 | -0.9% | 0.12% | +16.3% |
| Q4 2013 | $2,388,000 | +13.8% | 20,340 | +1.1% | 0.10% | +4.0% |
| Q3 2013 | $2,099,000 | +38.3% | 20,121 | +14.1% | 0.10% | +29.9% |
| Q2 2013 | $1,518,000 | – | 17,634 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,373,210 | $47,796,000 | 39.06% |
| Claren Road Asset Management, LLC | 77,527 | $1,561,000 | 18.46% |
| Okumus Fund Management Ltd. | 4,242,012 | $85,434,000 | 14.79% |
| Chou Associates Management | 1,446,843 | $29,139,000 | 11.12% |
| FARLEY CAPITAL L.P. | 307,458 | $6,192,000 | 9.65% |
| HAP Trading, LLC | 3,129,700 | $112,397,000 | 6.58% |
| Pershing Square Capital Management | 21,591,122 | $434,845,000 | 5.79% |
| NORTH TIDE CAPITAL, LLC | 2,500,000 | $50,350,000 | 5.61% |
| Convector Capital Management, LP | 192,000 | $3,867,000 | 5.34% |
| Nebula Capital Management, LP | 31,770 | $640,000 | 5.07% |